Trials / Sponsors / Electra Therapeutics Inc.
Electra Therapeutics Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs) T Cell Malignancies | Phase 1 | 2026-02-17 |
| Recruiting | Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) Secondary Hemophagocytic Lymphohistiocytosis (sHLH) | Phase 2 / Phase 3 | 2022-05-19 |
| Completed | Evaluation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ELA026 in Single and Multiple Healthy Volunteers | Phase 1 | 2021-10-18 |